Reta/Cag 12.5MG/2.5MG

$120.00

Retatrutide/Cagrilintide (12.5mg/2.5mg) is a dual-pathway research blend combining a multi-agonist incretin peptide with an amylin analog. It is used in professional studies exploring appetite regulation, energy expenditure, and metabolic signaling synergy.

  • Supports studies on satiety signaling, appetite control, and metabolic regulation

  • Ideal for research on energy balance, nutrient utilization, and glucose homeostasis

  • Useful for investigating multi-hormonal synergy between incretin pathways and amylin analogs

In stock

Vial Icon

Volume Discounts

Bulk Volume Discounts starting as low as 20 units per Product

beakers icon

Custom Labeling

3 Tiers of labeling: Unlabeled, Generic, and Custom Label

micro icon

Quality Guarantee

All products come with a 30-Day Quality Guarantee.

US-Based Support

US-based support available Monday - Friday 7-6pm ET

Description

CAS Number: N/A (research blend)
Molecular Formula: N/A (research blend)
Molecular Weight: N/A (research blend)
Form: Lyophilized Powder
Quantity: 12.5mg / 2.5mg vial
Purity: ≥ 98% (HPLC Verified)

Product Overview

Retatrutide/Cagrilintide (12.5mg/2.5mg) is a dual-compound research blend combining Retatrutide, a multi-receptor agonist active across GLP-1, GIP, and glucagon pathways, with Cagrilintide, a long-acting amylin analog. This combination provides a versatile model for studying multi-hormonal interactions related to appetite regulation, energy expenditure, and metabolic control.

By pairing an incretin-focused compound with an amylin mimetic, this formulation enables researchers to explore potential synergistic effects on satiety signaling, energy balance, and glucose homeostasis in controlled laboratory environments.

Intended Applications

  • Research involving metabolic regulation and weight-management pathways

  • Studies examining appetite suppression and satiety-related signaling

  • Investigations into energy balance, nutrient utilization, and glucose control

  • Explorations of synergistic mechanisms between incretin pathways and amylin analogs

Storage & Handling

  • Store lyophilized material at –20°C, protected from light and moisture.

  • Reconstitute using sterile bacteriostatic water under aseptic laboratory conditions.

  • After reconstitution, store refrigerated and use within appropriate research timelines.

  • Avoid repeated freeze–thaw cycles.

Professional Use Only - Legal Disclaimer

All PeptiMed products are classified as Professional Use Only (PUO) and are intended exclusively for qualified professionals, licensed facilities, and authorized organizations. These products are not approved by the FDA and are not intended for personal use, consumer use, or unsupervised application.

By purchasing or using PeptiMed products, you confirm that you are a properly licensed professional acting within the scope of your credentials and that you understand all regulatory, safety, and compliance obligations associated with handling these materials. Products must not be sold, supplied, or provided directly to consumers or used outside an appropriate professional environment.

All handling, storage, and use of PeptiMed products are undertaken at your own risk. PeptiMed assumes no responsibility for misuse, improper application, or any clinical, regulatory, or professional consequences resulting from their use.

Labeling Options

All labeled vials include product details and batch information including a QR Code* to the COA printed on each label

Custom White Label

Custom White-Label

Generic Label

Unlabeled Vial

*QR Codes coming in early 2026